| Document |
Document Title |
|
JPS6197259A |
PURPOSE: A novel cyclopentenone derivative is used as an synthetic intermediate to enable industrially advantageous production of prostaglandins which have a variety of pharmacological actions such as inhibition of blood platelet coagula...
|
|
JPS6115852B2 |
Ionyl-alkyl and ionyl-alkenyl ethers as flavorants for tobacco.
|
|
JPS6114159B2 |
Complexes of saponins with sterols are disclosed which possess the pharmaceutical activity of the free saponins, but which have reduced side-effects. Also disclosed are pharmaceutical compositions containing the complexes.
|
|
JPS6113454B2 |
A total synthesis of canthaxanthin or dinor-canthaxanthin, known food coloring agents, from pentols.
|
|
JPS6113469B2 |
Prostaglandin derivatives wherein the atom at the position 13 of the lower side-chain is replaced by nitrogen. The new compounds have abortifacient activity.
|
|
JPS6111959B2 |
PURPOSE:Steroid derivs. of formula I(Ris H or acyl), e.g. 5beta-cholest-24ene-3alpha-01-acetate.
|
|
JPS6147459A |
This invention covers a compound of the formula wherein R is hydrogen, lower alkyl; X is hydrogen, halo, trifluoromethyl, lower alkyl or lower alkoxy; Y is lower alkyl or wherein Z is hydrogen, halo, methyl, methoxy or trifluoromethyl; a...
|
|
JPS6143161A |
This invention covers a compound of the formulawherein R is hydrogen, lower alkyl and X is hydrogen, halo, trifluoromethyl, lower alkyl or lower alkoxy; and the wavy lines represent the a or β configuration with the proviso that when on...
|
|
JPS615458B2 |
|
|
JPS615473B2 |
|
|
JPS6133165A |
NEW MATERIAL:The compound of formula (R is H or OH). EXAMPLE: 1α,25-Dihydroxy-24,24-dimethyl-22E-dehydrovitamin D3. USE: Useful as a remedy for calcium dysbolism and osteoporosis. It has strong vitamin D activity. It has also carcinosta...
|
|
JPS614830B2 |
Novel acetylenic compounds useful as starting materials for the preparation of beta -damascenone. Process for their preparation and use thereof.
|
|
JPS6130554A |
PURPOSE: To provide a remedy having strong pharmacological effect (especially hypotensive and blood platelet coagulation inhibiting action, and containing an isomer of a prostaglandin-mimic compound having a specific steric configuration...
|
|
JPS6127959A |
NEW MATERIAL:A compound shown by the formula I (R1 is H, 1W4 alkyl, or cation; R2 is H, methyl, ethyl, vinyl, etc.; R3 is unsubstituted 4W8C aliphatic hydrocarbon, alicylic hydrocarbon, etc.; R4 and R5 are H, 2W7C acyl, tri(1W7C) hydroca...
|
|
JPS613783B2 |
Process for the manufacture of canthaxanthin by oxidizing beta -carotene, retro-dehydro-carotene or echinenone with a salt of chloric or bromic acid in the presence of a catalyst and of an inert diluent or solvent.
|
|
JPS613359B2 |
|
|
JPS6112657A |
PURPOSE: A carotene-containing oily substance is adsorbed onto a styrene-divinylbenzene copolymer and the oily substance is eluted with an alcohol, then brought into contact with a hydrophobic solvent which easily dissolves carotene to o...
|
|
JPS611423B2 |
|
|
JPS617215A |
PURPOSE: An antitumour agent containing a dihydroxycholecalciferol derivative as an active ingredient. CONSTITUTION: An antitumour agent obtained by dispersing a compound expressed by the formula is dispersed in a solid or liquid carrier...
|
|
JPS611079B2 |
|
|
JPS60260524A |
PURPOSE: A pharmaceutical preparation of unfatty emulsion of prostaglandin compound having improved stability of the compound, obtained by blending the prostaglandin compound useful as a hypotensor, an inhibitor against thrombosis format...
|
|
JPS60252459A |
Compounds are described of formula (1)in which n is 1 or 2;m is 2-5 and X is -CH=CH- or -CH2CH2-, or m is 1-4 and X is -CH=C=CH-;R1 is -H, C1-6 alkyl or C7-10 phenalkyl, Y substituted or unsubstituted 3-phenoxy-2-hydroxypropyl, and their...
|
|
JPS60502152A |
The invention provides a new derivative of vitamin D, 23,23-difluoro-25-hydroxycholecalciferol, a method for preparing said compound and various new intermediates utilized in such process. The compound is characterized by vitamin D-like ...
|
|
JPS60502153A |
The invention provides a new derivative of vitamin D, 23,23-difluoro-1,25-dihydroxycholecalciferol. The compound is characterized by vitamin D-like activity as evidenced by its ability to increase intestinal calcium transport. It is furt...
|
|
JPS6056715B2 |
Reactive iridoid derivates represented by the following general formula (wherein R represents a hydrogen atom, an alkyl group with 1 to 5 carbon atoms, an acyl group with 2 to 6 C atoms, an unsubstituted aralkyl group with 7 to 12 C atom...
|
|
JPS6056704B2 |
|
|
JPS6054933B2 |
|
|
JPS6051450B2 |
|
|
JPS6051457B2 |
|
|
JPS6049632B2 |
|
|
JPS60218372A |
Pharmaceutical preparations containing 4-oxo- or 4-hydroxy-1 3-cis-vitamin A acid as the active substance can be used for the treatment of acne or seborrhoea.
|
|
JPS6049189B2 |
|
|
JPS6048513B2 |
|
|
JPS60209562A |
PURPOSE: cis-2,2,3-Trimethyl-6-methylene-cyclohexylacetaldehyde, as a starting material, is converted into a novel intermediate to give the titled trans isomer- free compound, which is used as a durative flavor or modifier. CONSTITUTION:...
|
|
JPS6046094B2 |
|
|
JPS60197656A |
Prostaglandins of the 12-epi-PGF2 beta type, in particular 12-epi-PGF2 beta and 15-methyl-12-epi-PGF2 beta , their lower alkyl esters and their 15R-epimers are described. Moreover, a new, simple and stereoselective access to the prostagl...
|
|
JPS60193963A |
NEW MATERIAL:The compound of formula I [R is group of formula II or formula III (X is -NHCHO, -H=C=S, etc.)]. EXAMPLE: 6-(4-Methyl-4-cyclohexenyl)-2,6-dimethylhexane-3,5-diene. USE: An ultraviolet absorber and antioxidant. It has strong ...
|
|
JPS60190793A |
The invention relates to the preparation of 9β, 10a-5,7- diene steroids by irradiating the corresponding 9a, 10β steroids with filtered ultraviolet light of an antimony lamp.
|
|
JPS6043335B2 |
A dried and stabilized prostaglandin composition containing a prostaglandin E group compound with calcium lactate and/or amylopectin, and a stabilized pharmaceutical preparation for practical administration prepared from the said composi...
|
|
JPS6042769B2 |
|
|
JPS60184040A |
NEW MATERIAL:A cyclopentanone derivative expressed by formula I (R is carboxyl, alkoxycarbonyl, hydroxymethyl, protected hydroxymethyl or lower alkyl; X is -C≡C- or -CH2-CH2-). EXAMPLE: Methyl 8-[3-oxo-2-[2(2)-pentanyl]cyclopentyl]-6-o...
|
|
JPS6039673B2 |
Novel prostaglandin intermediates and process for the production thereof. Compounds, and process for the production thereof, useful in the production of (dl)-[1 alpha -hydroxy-3 beta -(35-tetrahydropyranyloxy-trans-1-octenyl)-4 alpha -te...
|
|
JPS6039663B2 |
|
|
JPS6038370B2 |
|
|
JPS60163859A |
NEW MATERIAL:A compound shown by the formula I (R1 is H, or OH; R2 is deuterium, or tritium). EXAMPLE: [1β-2H]-1α-hydroxybitamin D3. USE: A reagent for testing pharmaceutical activity. PREPARATION: A 1-position labeled previtamin D3 de...
|
|
JPS60161967A |
Sulfur-containing 6-ketoprostaglandins of the formula I I in which D is a bond, alkylene having 1-3 C atoms, cis-alkenylene having 2-5 C atoms or alkinylene having 2-5 C atoms, R1 is H, alkyl having 1-4 C atoms, aryl having 6-12 C atoms ...
|
|
JPS6036422B2 |
Prostaglandin analogues of the formula:- (wherein R represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms, the wavy line indicates attachment in alpha - or beta -configuration or a mi...
|
|
JPS6036435B2 |
Tricyclic cyanoepoxides of the formula WHEREIN R12 is R13 ¦(1) -C-CgH2g-CH3 ¦ R14 -CH2C2H5(2) ANGLE C=C ANGLE HH or WHEREIN CgH2g, R13, R14, s, T, Z, and DIFFERENCE are as defined hereinafter; WHEREIN R21 is a blocking group as defined...
|
|
JPS60156666A |
NEW MATERIAL:A compound shown by the formula I [R is lower acyl, or group shown by the formula II (R1 and R2 are H, or lower alkyl; R3 is lower alkyl; in wavy line R1 and R3 form independent group, respectively, or form covalent bond thr...
|
|
JPS6034947B2 |
|
